All lobbying filings
CRANE STRATEGIES
CRANE STRATEGIES filed a Q2 report for REGENERON PHARMACEUTICALS, INC. on July 1, 2025, reporting $50,000 in lobbying income.
Lobbying for REGENERON PHARMACEUTICALS, INC. · Biopharmaceutical development and manufacturing
Filing · LD-2 quarterly report
Q2 report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 1, 2025
Income
$50,000
What the client paid this registrant for the period.
Client based in
New York
Lobbyists on this filing
1
-
STEVEN CRANEPreviously held: Staff assistant, Senator Barbara Mikulski
Government bodies contacted
3
Lobbying activity
1
Biodefense funding